Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer

BACKGROUND: Although bevacizumab is an important treatment for metastatic colorectal cancer (CRC), not all patients with CRC benefit from it; in unselected patient populations, only modest survival benefits have been reported. METHODS: We evaluated clinical outcomes in 110 patients using comprehensi...

Descripción completa

Detalles Bibliográficos
Autores principales: LIM, SUNG HEE, CHO, HEE JIN, KIM, KYOUNG-MEE, LIM, HO YEONG, KANG, WON KI, LEE, JEEYUN, PARK, YOUNG SUK, KIM, HEE CHEOL, KIM, SEUNG TAE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513961/
https://www.ncbi.nlm.nih.gov/pubmed/37744267
http://dx.doi.org/10.32604/or.2023.030374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513961/
https://www.ncbi.nlm.nih.gov/pubmed/37744267
http://dx.doi.org/10.32604/or.2023.030374

Ejemplares similares